Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 31 | 2025 | 1175 | 7.200 |
Why?
|
| Extracorporeal Membrane Oxygenation | 17 | 2025 | 659 | 4.240 |
Why?
|
| Heart-Assist Devices | 16 | 2025 | 1085 | 4.030 |
Why?
|
| Aortic Aneurysm, Thoracic | 17 | 2025 | 705 | 3.860 |
Why?
|
| Vasoplegia | 4 | 2025 | 18 | 3.070 |
Why?
|
| Perioperative Care | 7 | 2025 | 212 | 1.820 |
Why?
|
| Heart Failure | 10 | 2024 | 2398 | 1.770 |
Why?
|
| Postoperative Complications | 21 | 2025 | 3129 | 1.640 |
Why?
|
| Vascular Surgical Procedures | 6 | 2024 | 553 | 1.640 |
Why?
|
| Thoracic Surgical Procedures | 3 | 2023 | 107 | 1.610 |
Why?
|
| Shock | 2 | 2023 | 99 | 1.510 |
Why?
|
| Shock, Cardiogenic | 6 | 2025 | 213 | 1.500 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2023 | 462 | 1.470 |
Why?
|
| Patient Readmission | 10 | 2025 | 425 | 1.300 |
Why?
|
| Postoperative Care | 3 | 2020 | 311 | 1.170 |
Why?
|
| Blood Vessel Prosthesis Implantation | 6 | 2025 | 787 | 1.160 |
Why?
|
| Critical Care | 5 | 2024 | 686 | 1.150 |
Why?
|
| Thoracic Surgery | 6 | 2024 | 166 | 1.130 |
Why?
|
| Acute Kidney Injury | 5 | 2025 | 670 | 1.130 |
Why?
|
| Retrospective Studies | 42 | 2025 | 17367 | 1.100 |
Why?
|
| Humans | 102 | 2025 | 132093 | 1.090 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2025 | 373 | 1.070 |
Why?
|
| Aortic Diseases | 4 | 2024 | 197 | 1.010 |
Why?
|
| Respiratory Insufficiency | 3 | 2023 | 247 | 1.000 |
Why?
|
| Anticoagulants | 7 | 2025 | 609 | 0.990 |
Why?
|
| Aorta, Thoracic | 6 | 2025 | 540 | 0.940 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2021 | 425 | 0.920 |
Why?
|
| Coronary Artery Bypass | 8 | 2025 | 537 | 0.910 |
Why?
|
| Treatment Outcome | 32 | 2025 | 13015 | 0.890 |
Why?
|
| Stroke | 4 | 2024 | 1082 | 0.870 |
Why?
|
| Intensive Care Units | 4 | 2023 | 524 | 0.870 |
Why?
|
| Heparin | 2 | 2025 | 212 | 0.820 |
Why?
|
| Thrombelastography | 1 | 2024 | 63 | 0.810 |
Why?
|
| Risk Factors | 28 | 2025 | 10936 | 0.790 |
Why?
|
| Mitral Valve | 5 | 2022 | 270 | 0.780 |
Why?
|
| Middle Aged | 35 | 2025 | 28981 | 0.770 |
Why?
|
| Risk Assessment | 19 | 2025 | 3727 | 0.760 |
Why?
|
| Societies, Medical | 5 | 2025 | 778 | 0.760 |
Why?
|
| Organ Dysfunction Scores | 1 | 2022 | 50 | 0.750 |
Why?
|
| Shock, Septic | 1 | 2023 | 155 | 0.730 |
Why?
|
| Myocardial Ischemia | 2 | 2021 | 341 | 0.730 |
Why?
|
| Hyponatremia | 1 | 2022 | 74 | 0.700 |
Why?
|
| Monitoring, Intraoperative | 1 | 2021 | 132 | 0.680 |
Why?
|
| Sarcopenia | 1 | 2021 | 57 | 0.670 |
Why?
|
| Embolectomy | 1 | 2020 | 9 | 0.660 |
Why?
|
| Cardiomyopathies | 2 | 2021 | 509 | 0.650 |
Why?
|
| Renal Replacement Therapy | 2 | 2021 | 158 | 0.650 |
Why?
|
| Aged | 29 | 2025 | 21456 | 0.650 |
Why?
|
| Delirium | 1 | 2020 | 61 | 0.630 |
Why?
|
| Splenectomy | 1 | 2019 | 62 | 0.610 |
Why?
|
| Heart Valve Prosthesis | 4 | 2022 | 331 | 0.600 |
Why?
|
| Atrial Fibrillation | 2 | 2023 | 738 | 0.590 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 154 | 0.580 |
Why?
|
| Patient Handoff | 1 | 2018 | 24 | 0.580 |
Why?
|
| Nutrition Assessment | 1 | 2019 | 127 | 0.580 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 256 | 0.570 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 216 | 0.570 |
Why?
|
| Airway Extubation | 1 | 2019 | 70 | 0.570 |
Why?
|
| Operating Rooms | 1 | 2018 | 76 | 0.570 |
Why?
|
| Male | 37 | 2025 | 64951 | 0.560 |
Why?
|
| Severity of Illness Index | 3 | 2023 | 3086 | 0.560 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 375 | 0.550 |
Why?
|
| Hyperoxia | 1 | 2019 | 130 | 0.550 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 273 | 0.550 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 189 | 0.540 |
Why?
|
| Health Care Costs | 1 | 2020 | 407 | 0.540 |
Why?
|
| Renal Dialysis | 2 | 2024 | 947 | 0.530 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2018 | 194 | 0.530 |
Why?
|
| Stomach | 1 | 2019 | 273 | 0.520 |
Why?
|
| Female | 37 | 2025 | 70715 | 0.510 |
Why?
|
| Registries | 5 | 2025 | 1591 | 0.510 |
Why?
|
| Patient Selection | 3 | 2020 | 730 | 0.500 |
Why?
|
| Coronary Artery Disease | 5 | 2025 | 893 | 0.480 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 470 | 0.480 |
Why?
|
| Hospital Mortality | 5 | 2025 | 1078 | 0.470 |
Why?
|
| Time Factors | 12 | 2025 | 6448 | 0.470 |
Why?
|
| Lung Transplantation | 3 | 2025 | 336 | 0.450 |
Why?
|
| Incidental Findings | 2 | 2019 | 131 | 0.440 |
Why?
|
| Hemodynamics | 3 | 2025 | 864 | 0.430 |
Why?
|
| Machine Learning | 5 | 2025 | 348 | 0.430 |
Why?
|
| Bioprosthesis | 3 | 2023 | 119 | 0.420 |
Why?
|
| Paraplegia | 2 | 2025 | 96 | 0.390 |
Why?
|
| Heart Ventricles | 3 | 2021 | 785 | 0.380 |
Why?
|
| Adult | 16 | 2025 | 31560 | 0.380 |
Why?
|
| Social Class | 2 | 2025 | 206 | 0.360 |
Why?
|
| Thrombosis | 2 | 2022 | 528 | 0.350 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2013 | 185 | 0.350 |
Why?
|
| Vasoconstrictor Agents | 2 | 2023 | 141 | 0.350 |
Why?
|
| Atrial Appendage | 1 | 2011 | 74 | 0.340 |
Why?
|
| Length of Stay | 5 | 2024 | 1380 | 0.330 |
Why?
|
| Angiotensin II | 2 | 2021 | 163 | 0.320 |
Why?
|
| Recovery of Function | 2 | 2024 | 461 | 0.320 |
Why?
|
| Aftercare | 2 | 2021 | 155 | 0.310 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 503 | 0.310 |
Why?
|
| Consensus | 4 | 2025 | 656 | 0.300 |
Why?
|
| Prognosis | 5 | 2022 | 5013 | 0.300 |
Why?
|
| Tracheostomy | 2 | 2023 | 203 | 0.300 |
Why?
|
| Patient Discharge | 2 | 2024 | 511 | 0.290 |
Why?
|
| Thrombectomy | 1 | 2009 | 112 | 0.290 |
Why?
|
| Surgeons | 2 | 2024 | 280 | 0.290 |
Why?
|
| Databases, Factual | 5 | 2025 | 1230 | 0.290 |
Why?
|
| United States | 11 | 2025 | 11652 | 0.260 |
Why?
|
| Blood Pressure | 2 | 2023 | 1402 | 0.250 |
Why?
|
| Heart | 3 | 2021 | 698 | 0.250 |
Why?
|
| Heart Transplantation | 2 | 2021 | 875 | 0.250 |
Why?
|
| Lung | 3 | 2023 | 1556 | 0.240 |
Why?
|
| Endovascular Procedures | 3 | 2025 | 785 | 0.230 |
Why?
|
| Antithrombins | 1 | 2025 | 51 | 0.230 |
Why?
|
| Pandemics | 3 | 2021 | 1185 | 0.220 |
Why?
|
| Arterial Pressure | 1 | 2025 | 127 | 0.220 |
Why?
|
| Kidney | 2 | 2024 | 1339 | 0.220 |
Why?
|
| Aneurysm, False | 1 | 2025 | 93 | 0.210 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2004 | 99 | 0.210 |
Why?
|
| Prosthesis Design | 3 | 2023 | 670 | 0.210 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2020 | 260 | 0.210 |
Why?
|
| Incidence | 4 | 2025 | 3370 | 0.210 |
Why?
|
| Catheterization | 1 | 2024 | 241 | 0.200 |
Why?
|
| Survival Analysis | 3 | 2022 | 1571 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 1307 | 0.200 |
Why?
|
| Survival Rate | 4 | 2024 | 2192 | 0.200 |
Why?
|
| Creatinine | 2 | 2022 | 413 | 0.190 |
Why?
|
| Patient Care Team | 2 | 2024 | 574 | 0.190 |
Why?
|
| Blood Coagulation | 1 | 2023 | 129 | 0.190 |
Why?
|
| APACHE | 1 | 2022 | 50 | 0.190 |
Why?
|
| Aorta | 2 | 2022 | 554 | 0.180 |
Why?
|
| Surgical Wound Infection | 1 | 2024 | 271 | 0.180 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 348 | 0.180 |
Why?
|
| Administration, Oral | 1 | 2023 | 699 | 0.170 |
Why?
|
| Peripheral Arterial Disease | 1 | 2025 | 321 | 0.170 |
Why?
|
| Telecommunications | 1 | 2020 | 22 | 0.170 |
Why?
|
| Muscle Proteins | 1 | 2003 | 404 | 0.160 |
Why?
|
| Acute Disease | 2 | 2020 | 1161 | 0.160 |
Why?
|
| ROC Curve | 1 | 2022 | 600 | 0.160 |
Why?
|
| China | 1 | 2021 | 291 | 0.160 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2020 | 88 | 0.160 |
Why?
|
| Spinal Cord | 1 | 2021 | 276 | 0.160 |
Why?
|
| Goals | 1 | 2020 | 134 | 0.160 |
Why?
|
| Splenic Diseases | 1 | 2019 | 31 | 0.160 |
Why?
|
| Congresses as Topic | 1 | 2020 | 186 | 0.150 |
Why?
|
| Allied Health Personnel | 1 | 2020 | 73 | 0.150 |
Why?
|
| Mitochondria | 1 | 2024 | 751 | 0.150 |
Why?
|
| Health Resources | 1 | 2020 | 129 | 0.150 |
Why?
|
| Ventricular Function, Right | 1 | 2020 | 119 | 0.150 |
Why?
|
| Critical Care Nursing | 1 | 2019 | 6 | 0.150 |
Why?
|
| Equipment Design | 1 | 2021 | 610 | 0.150 |
Why?
|
| Pulmonary Alveoli | 1 | 2019 | 141 | 0.150 |
Why?
|
| Medical Staff, Hospital | 1 | 2019 | 96 | 0.150 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 238 | 0.150 |
Why?
|
| Nutritional Support | 1 | 2019 | 55 | 0.150 |
Why?
|
| Spleen | 1 | 2019 | 271 | 0.150 |
Why?
|
| Aortic Valve | 4 | 2023 | 485 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 2087 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 163 | 0.140 |
Why?
|
| Patient Transfer | 1 | 2018 | 110 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 305 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2020 | 368 | 0.140 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2022 | 304 | 0.130 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 152 | 0.130 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2020 | 246 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 309 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 628 | 0.130 |
Why?
|
| Algorithms | 2 | 2021 | 1724 | 0.130 |
Why?
|
| Guideline Adherence | 1 | 2019 | 396 | 0.130 |
Why?
|
| Disease Management | 1 | 2020 | 565 | 0.130 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 378 | 0.120 |
Why?
|
| Vaccination | 1 | 2021 | 1017 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1160 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 485 | 0.120 |
Why?
|
| Texas | 2 | 2022 | 3632 | 0.120 |
Why?
|
| Hospitals | 3 | 2023 | 437 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 573 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2019 | 408 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 1062 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 7125 | 0.100 |
Why?
|
| Stents | 1 | 2019 | 874 | 0.100 |
Why?
|
| Delphi Technique | 2 | 2025 | 240 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 2164 | 0.090 |
Why?
|
| Biomarkers | 1 | 2021 | 3403 | 0.090 |
Why?
|
| Propensity Score | 2 | 2024 | 255 | 0.090 |
Why?
|
| Elective Surgical Procedures | 2 | 2025 | 161 | 0.090 |
Why?
|
| Carney Complex | 1 | 2010 | 2 | 0.090 |
Why?
|
| Quality of Life | 1 | 2021 | 2159 | 0.080 |
Why?
|
| Obesity | 1 | 2021 | 2397 | 0.080 |
Why?
|
| Sex Factors | 2 | 2024 | 1352 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 899 | 0.080 |
Why?
|
| Thoracotomy | 1 | 2010 | 111 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 846 | 0.080 |
Why?
|
| Aortography | 1 | 2009 | 183 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2009 | 165 | 0.070 |
Why?
|
| Heart Atria | 1 | 2010 | 336 | 0.070 |
Why?
|
| Cardiac Catheterization | 1 | 2011 | 671 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 1126 | 0.070 |
Why?
|
| Reoperation | 2 | 2025 | 850 | 0.060 |
Why?
|
| Comorbidity | 2 | 2022 | 1610 | 0.060 |
Why?
|
| Adolescent | 2 | 2020 | 20530 | 0.060 |
Why?
|
| Pipecolic Acids | 1 | 2025 | 7 | 0.060 |
Why?
|
| Hirudins | 1 | 2025 | 36 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 5407 | 0.060 |
Why?
|
| Anastomosis, Surgical | 1 | 2025 | 167 | 0.060 |
Why?
|
| Age Factors | 2 | 2018 | 2922 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 1 | 2024 | 124 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2004 | 67 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 1304 | 0.050 |
Why?
|
| Spirometry | 1 | 2023 | 75 | 0.050 |
Why?
|
| Diaphragm | 1 | 2004 | 99 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2025 | 283 | 0.050 |
Why?
|
| Income | 1 | 2024 | 136 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 79 | 0.050 |
Why?
|
| Arginine | 1 | 2025 | 343 | 0.050 |
Why?
|
| Forced Expiratory Volume | 1 | 2023 | 173 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2025 | 155 | 0.050 |
Why?
|
| Educational Status | 1 | 2024 | 294 | 0.050 |
Why?
|
| Device Removal | 1 | 2004 | 225 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2003 | 168 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 688 | 0.050 |
Why?
|
| Mechanics | 1 | 2002 | 2 | 0.050 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2003 | 130 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2025 | 1350 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2025 | 800 | 0.040 |
Why?
|
| Canada | 1 | 2022 | 337 | 0.040 |
Why?
|
| Animals | 3 | 2011 | 34912 | 0.040 |
Why?
|
| Triage | 1 | 2022 | 148 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2003 | 596 | 0.040 |
Why?
|
| Poverty | 1 | 2024 | 434 | 0.040 |
Why?
|
| Heart Valve Diseases | 1 | 2002 | 178 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2021 | 225 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 373 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2021 | 334 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 323 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2312 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2003 | 548 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 328 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2021 | 231 | 0.040 |
Why?
|
| Medicare | 1 | 2022 | 447 | 0.040 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 69 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 292 | 0.040 |
Why?
|
| Palliative Care | 1 | 2022 | 457 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 1460 | 0.030 |
Why?
|
| Apoptosis | 1 | 2003 | 1900 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1440 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 1699 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1966 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2019 | 515 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1836 | 0.030 |
Why?
|
| Myxoma | 1 | 2010 | 29 | 0.020 |
Why?
|
| Sternotomy | 1 | 2010 | 43 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 5169 | 0.020 |
Why?
|
| Heart Neoplasms | 1 | 2010 | 105 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2010 | 246 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7548 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9938 | 0.020 |
Why?
|